PubMed:3840699
Annnotations
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 111-114 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
| T2 | 347-350 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
| T3 | 364-369 | Glycan | denotes | NeuAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T4 | 646-649 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
| T5 | 711-716 | Glycan | denotes | NeuAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T6 | 922-925 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 53-61 | Disease | denotes | melanoma | http://purl.obolibrary.org/obo/MONDO_0005105 |
| T2 | 290-308 | Disease | denotes | malignant melanoma | http://purl.obolibrary.org/obo/MONDO_0005105 |
| T3 | 842-850 | Disease | denotes | melanoma | http://purl.obolibrary.org/obo/MONDO_0005105 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 53-61 | Phenotype | denotes | melanoma | HP:0002861 |
| T2 | 290-308 | Phenotype | denotes | malignant melanoma | HP:0002861 |
| T3 | 842-850 | Phenotype | denotes | melanoma | HP:0002861 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 111-114 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
| T2 | 347-350 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
| T3 | 364-369 | Glycan | denotes | NeuAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T4 | 646-649 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
| T5 | 711-716 | Glycan | denotes | NeuAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T6 | 922-925 | Glycan | denotes | GD3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 53-61 | Phenotype | denotes | melanoma | HP:0002861 |
| T2 | 290-308 | Phenotype | denotes | malignant melanoma | HP:0002861 |
| T3 | 842-850 | Phenotype | denotes | melanoma | HP:0002861 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 0-5 | Organism | denotes | Mouse | 10088|10090 |
| T3 | 181-186 | Organism | denotes | mouse | 10088|10090 |
| T5 | 284-289 | Organism | denotes | human | 9606 |
| T6 | 576-581 | Organism | denotes | mouse | 10088|10090 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-178 | Sentence | denotes | Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside. |
| T2 | 179-423 | Sentence | denotes | A mouse monoclonal IgM antibody, 4.2, has previously been shown to bind preferentially to the surface of human malignant melanoma cells and to have specificity for the GD3 ganglioside (NeuAc alpha 2----8NeuAc alpha 2----3Gal beta 1----4GlcCer). |
| T3 | 424-827 | Sentence | denotes | Using overlay of antibodies on thin-layer chromatograms with glycolipids of various sources, it was shown that antibody 4.2, a further IgM and two IgG3 mouse monoclonal antibodies, selected on the basis of reactivity with GD3, also bound with similar strength to the structural analogue NeuAc alpha 2----8NeuAc alpha 2----3Gal beta 1----4GlcNac beta 1----3Gal beta 1----4GlcCer or disialylparagloboside. |
| T4 | 828-960 | Sentence | denotes | The SK-MEL 28 melanoma cell line used for immunization was shown to contain a large amount of GD3 but to lack disialylparagloboside. |
| T5 | 961-1098 | Sentence | denotes | The demonstrated cross-reactivity may be of importance when considering the use of these antibodies for biochemical and medical purposes. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 53-61 | Disease | denotes | melanoma | MONDO:0005105 |
| T2 | 290-308 | Disease | denotes | malignant melanoma | MONDO:0005105 |
| T3 | 842-850 | Disease | denotes | melanoma | MONDO:0005105 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 0-5 | OrganismTaxon | denotes | Mouse | 10088|10090 |
| T3 | 181-186 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T5 | 284-289 | OrganismTaxon | denotes | human | 9606 |
| T6 | 576-581 | OrganismTaxon | denotes | mouse | 10088|10090 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 460-465 | Body_part | denotes | layer | http://purl.obolibrary.org/obo/UBERON_0000119|http://purl.obolibrary.org/obo/UBERON_0022303 |